Skip to main content
Caplight Logo









Atonco

Atonco

Private
Saint-HerblainHealthcare & Life Scienceshttps://atonco-pharma.com/

Last Round

VC Round

Aug 1, 2025

Total Funding Raised

$6.48M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Atonco is a biotechnology company that develops innovative radiopharmaceutical therapies using alpha-emitting radionuclides, such as astatine-211, to treat cancers resistant to conventional therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

radiopharmaceuticaltargeted alpha therapyalpha-immunotherapyastatine-211TATprecision oncologybiotechclinical-stage biotechradiolabelingdrug developmenttheranosticscancer therapytargeted therapybiotech licensingclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Atonco Comparables

Compare Atonco with similar companies based on industry and business-model similarity.

Atonco comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alpha Fusion Inc.
84%
Abdera Therapeutics
82%
AdvanCell
80%

Atonco Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 1, 2025
SeedApr 4, 2023

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 185% MoM, from 534 to 1.5K.

  • Jun 19, 2026

    Monthly visitors grew 121% MoM.

Atonco Filings

Explore SEC and related filing metadata, where available.

Atonco filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Atonco's valuation, stock price, and market status.

Is Atonco a public or private company?

Atonco is a private company.

What is the current stock price of Atonco?

Atonco is a private company with no public stock price. No recent secondary market data is available.

How much is Atonco worth (valuation)?

Valuation information for Atonco is not publicly available.

Can I buy Atonco stock?

Atonco shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Atonco's last funding round?

Atonco's most recent funding round was VC Round on August 1, 2025.

Who are the main investors in Atonco?

Investor information for Atonco is not publicly disclosed.

Will Atonco IPO soon?

No public IPO plans have been announced for Atonco.

How can I track Atonco secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Atonco's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSaint-Herblain
Employee Range7
Year Founded2019
Last FundingAug 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?